Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
CRDO enters its October 12 earnings report in an unusual spot: the stock is up 29% in a month, shorts have been cutting exposure, and analysts are still bullish on the name even after trimming targets following last quarter's post-earnings drop.
The short side has been unwinding steadily this week. Short interest fell nearly 8% on October 7 alone, bringing the total to 5.5% of the free float, down from a recent peak above 6% at the start of October. That month-long build, interest rose 55% from late August through early October, has now started to reverse just as the stock approaches its next print. The borrow market tells a consistent story: availability is extremely loose at over 1,480%, meaning there are roughly 15 shares available to lend for every one currently borrowed. Cost to borrow is just 0.35%, well below where it was a month ago. There is no squeeze pressure here. The ORTEX short score has drifted lower all week, reaching 38.5 on October 7 from above 41 at the start of the month. The retreat in both short interest and the short score as the stock rallies hard into earnings suggests shorts are not pressing the trade ahead of the catalyst.
Options positioning is essentially neutral. The put/call ratio sits at 0.96, barely a quarter of a standard deviation above its 20-day average of 0.95. The range over the past year runs from 0.68 at the bullish extreme to 1.36 at the fearful extreme, and the current reading is squarely in the middle. Options traders are neither hedging aggressively nor loading up on upside calls; the market is treating this as a wait-and-see setup ahead of Monday's release.
The analyst community remains constructive despite a round of target cuts after last quarter's earnings. Stifel trimmed its target from $350 to $310 earlier this week while keeping its Buy rating. Mizuho and JP Morgan made similar moves in September, both lowering targets but holding positive ratings after the previous print disappointed. The mean target sits at $279, above the current price of $220, implying roughly 27% upside on the Street's base case. The bull argument is straightforward: fiscal Q4 revenue of $437 million grew 157% year over year, EPS of $1.16 beat estimates, and management guided for over 80% revenue growth in fiscal 2027 with optical sales topping $600 million. Bears push back on margin concentration risk. Non-GAAP gross margin held at 68.3%, but management guided it roughly flat while the DustPhotonics integration and heavier optical and hardware mix point toward a long-term range of 63 to 65%. Four customers still account for roughly 87% of revenue, leaving the story heavily dependent on hyperscaler capex cycles holding up. The EPS momentum factor score of 85 on a 30-day basis reflects recent estimate revision strength, though the 90-day reading at 62 is more moderate.
The historical reaction pattern is stark enough to warrant attention. The September 2026 print delivered a 27% decline on the day, and the five-day move was nearly identical. That single data point sets a clear reference for how much the market can move on a miss or a guidance reset even when the underlying growth story is intact. Correlated peers had a more mixed week: ENTG gained nearly 8%, ALAB added 7.4%, and LRCX was roughly flat, while ONTO and FORM fell. CRDO's 13% weekly gain stands out against that group, suggesting the stock has moved on company-specific momentum rather than a broad sector bid.
Wikipedia attention for CRDO registered a z-score of 2.74 against its own 90-day history as of September 22, the highest retail attention reading in the dataset window. That kind of spike in retail interest typically accompanies a sharp price move and elevated pre-earnings chatter rather than being a signal about the business itself, but it does confirm the stock is drawing more eyeballs than usual heading into the print.
The central question going into October 12 is whether guidance for the fiscal year, particularly the optical revenue ramp and the margin trajectory as DustPhotonics consolidates fully, lands within the range the Street is already pricing in after a month of aggressive share price recovery.
See the live data behind this article on ORTEX.
Open CRDO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
